Our Members

Novartis is reimagining medicine to improve and extend people’s lives. We deliver high-value medicines that alleviate society’s greatest disease burdens through technology leadership in R&D and novel access approaches. In our quest to find new medicines, we consistently rank among the world’s top companies investing in research and development. About 108,000 people of more than 140 nationalities work together to bring Novartis products to nearly 800 million people around the world

For Novartis, Corporate Responsibility is inextricably linked to its business strategy. It rules from end to end the company, from the strategic planning and development to execution and helps us focus on the areas where we can have the most material impacts. Our approach is absolutely in line with our mission: to help our fellow citizens live longer and with better quality of life, re-imagining medicine. In this journey we have the support of our people, our most important asset and driving force, simultaneously with the Management’s commitment and participation. Our patient-centric approach is a point of reference in the Corporate Responsibility formulation, which is based on three strategic priorities:

1. Holding ourselves to the highest ethical standards.
2. Being part of the solution on access to healthcare.
3. Being a responsible citizen.